Cargando…
Antidepressant mechanism of ketamine: perspective from preclinical studies
A debilitating mental disorder, major depressive disorder is a leading cause of global disease burden. Existing antidepressant drugs are not adequate for the majority of depressed patients, and large clinical studies have demonstrated their limited efficacy and slow response onset. Growing evidence...
Autores principales: | Scheuing, Lisa, Chiu, Chi-Tso, Liao, Hsiao-Mei, Chuang, De-Maw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508505/ https://www.ncbi.nlm.nih.gov/pubmed/26257598 http://dx.doi.org/10.3389/fnins.2015.00249 |
Ejemplares similares
-
The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress
por: Chiu, Chi-Tso, et al.
Publicado: (2015) -
Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?
por: Scheuing, Lisa, et al.
Publicado: (2014) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013) -
Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
por: Xu, Songbai, et al.
Publicado: (2022) -
Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
por: Ho, Ming-Fen, et al.
Publicado: (2019)